The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janusz, M. J.
Right arrow Articles by Doherty, N. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janusz, M. J.
Right arrow Articles by Doherty, N. S.

The Journal of Immunology, Vol 146, Issue 11 3922-3928, Copyright © 1991 by American Association of Immunologists


ARTICLES

Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G

MJ Janusz and NS Doherty
Marion Merrell Dow Research Institute, Cincinnati, OH 45054.

The granule proteases of human neutrophils are thought to be responsible for the connective tissue destruction associated with certain inflammatory diseases. Using a model system for the degradation of a macromolecular connective tissue substrate, purified neutrophil elastase and cathepsin G were both individually able to degrade cartilage matrix proteoglycan and this degradation was blocked by the appropriate specific inhibitors. Neutrophil granule lysate also produced cartilage matrix degradation but little inhibition of degradation occurred when either elastase or cathepsin G inhibitor was used alone. However, a combination of elastase and cathepsin G inhibitors each at 100 microM or each at 10 microM blocked cartilage matrix degradation by 89% +/- 1 and 65% +/- 9 (mean +/- SEM, n = 3), respectively. The magnitude of the cartilage degradation mediated by neutrophil lysate, and its sensitivity to specific inhibitors, was reproduced using purified elastase and cathepsin G at the concentrations at which they are present in neutrophil lysate. Human neutrophils stimulated with opsonized zymosan degraded cartilage matrix in a dose-dependent manner in the presence of serum antiproteases. Supernatants from stimulated neutrophils cultured in the presence of serum did not degrade cartilage matrix, indicating that neutrophil mediated degradation in the presence of serum was confined to the protected subjacent region between the inflammatory cell and the substratum. A combination of elastase and cathepsin G inhibitors each at 500 microM or each at 100 microM blocked subjacent cartilage matrix degradation by stimulated human neutrophils by 91% +/- 3 and 54% +/- 8 (mean +/- SEM, n = 5), respectively, whereas either the elastase or cathepsin G inhibitor alone was much less effective. These studies demonstrate that neutrophil-mediated cartilage matrix degradation is produced primarily by elastase and cathepsin G. Furthermore, these results support the hypothesis that inflammatory neutrophils form zones of close contact with substratum that exclude serum antiproteases and that this subjacent degradation of cartilage matrix by stimulated neutrophils can be blocked by a combination of synthetic elastase and cathepsin G inhibitors.


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. S. Bonder, M. N. Ajuebor, L. D. Zbytnuik, P. Kubes, and M. G. Swain
Essential Role for Neutrophil Recruitment to the Liver in Concanavalin A-Induced Hepatitis
J. Immunol., January 1, 2004; 172(1): 45 - 53.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Kapui, M. Varga, K. Urban-Szabo, E. Mikus, T. Szabo, J. Szeredi, S. Batori, O. Finance, and P. Aranyi
Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 451 - 459.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Samis, M. Garrett, R. P. Manuel, M. E. Nesheim, and A. R. Giles
Human Neutrophil Elastase Activates Human Factor V but Inactivates Thrombin-Activated Human Factor V
Blood, August 1, 1997; 90(3): 1065 - 1074.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Schick, Y. Kamachi, A. J. Bartuski, S. Cataltepe, N. M. Schechter, P. A. Pemberton, and G. A. Silverman
Squamous Cell Carcinoma Antigen 2Is a Novel Serpin That Inhibits the Chymotrypsin-like Proteinases Cathepsin G and Mast Cell Chymase
J. Biol. Chem., January 17, 1997; 272(3): 1849 - 1855.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.